Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Gautam

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nature Reviews. Drug Discovery|December 16, 2014
Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging marketsAjay Gautam
Nature Reviews. Drug Discovery|September 25, 2024
A tale of two ecosystems: the biopharma landscape in China and IndiaAjay Gautam
Nature Reviews. Drug Discovery|July 8, 2017
Market watch: Strategies for biosimilars in emerging marketsAjay Gautam
Nature Reviews. Drug Discovery|March 22, 2025
Life science ecosystems in Asia: biomedical innovation trends over the past decadeAjay Gautam
Nature Reviews. Drug Discovery|July 1, 2026
R&D productivity trends for biopharma companies in Asia and emerging marketsAjay Gautam
Nature Reviews. Drug Discovery|September 2, 2014
Market watch: a framework for biomedical innovation in emerging marketsAjay Gautam, Steve Yang
Drug Discovery Today|October 20, 2015
The changing model of big pharma: impact of key trendsAjay Gautam, Xiaogang Pan
Drug Discovery Today|February 22, 2015
Biopharma CRO industry in China: landscape and opportunitiesChristine Xia, Ajay Gautam
Current Cancer Drug Targets|July 23, 2003
Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol deliveryAjay Gautam, Nadezhda Koshkina
Nature Reviews. Drug Discovery|July 11, 2015
Market watch: Therapeutic area 'heat map' for emerging marketsAjay Gautam, Lily Li, Kumar Srinivasan
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nature Reviews. Drug Discovery|December 16, 2014
Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging marketsAjay Gautam
Nature Reviews. Drug Discovery|September 25, 2024
A tale of two ecosystems: the biopharma landscape in China and IndiaAjay Gautam
Nature Reviews. Drug Discovery|July 8, 2017
Market watch: Strategies for biosimilars in emerging marketsAjay Gautam
Nature Reviews. Drug Discovery|March 22, 2025
Life science ecosystems in Asia: biomedical innovation trends over the past decadeAjay Gautam
Nature Reviews. Drug Discovery|July 1, 2026
R&D productivity trends for biopharma companies in Asia and emerging marketsAjay Gautam
Nature Reviews. Drug Discovery|September 2, 2014
Market watch: a framework for biomedical innovation in emerging marketsAjay Gautam, Steve Yang
Drug Discovery Today|October 20, 2015
The changing model of big pharma: impact of key trendsAjay Gautam, Xiaogang Pan
Drug Discovery Today|February 22, 2015
Biopharma CRO industry in China: landscape and opportunitiesChristine Xia, Ajay Gautam
Current Cancer Drug Targets|July 23, 2003
Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol deliveryAjay Gautam, Nadezhda Koshkina
Nature Reviews. Drug Discovery|July 11, 2015
Market watch: Therapeutic area 'heat map' for emerging marketsAjay Gautam, Lily Li, Kumar Srinivasan
Pageof 3